Shares in Tokyo-listed Nxera Pharma slid 5% at market open after Boehringer walked away from the neurological assets.
E-cigarettes, nicotine pouches, and heated tobacco hurt blood vessels, increase heart disease risk. All nicotine products ...
The perception of GLP-1s — and the people who use them — is getting better, but work still must be done to avoid stigma.
By Michael Erman, Jarrett Renshaw and Patrick Wingrove Dec 19 (Reuters) - AbbVie, Bristol Myers Squibb, Gilead, Merck and other drugmakers are expected on Friday afternoon to announce agreements with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback